Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage

The aim of the study is to determine if thromboelastography parameters can be predictive of severe post partum hemorrhage.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Post Partum Hemorrhage Female Urogenital Diseases and Pregnancy Complications Hemorrhage Obstetric Labor Complications Pathologic Processes Pathological Conditions, Signs and Symptoms Postpartum Hemorrhage Pregnancy Complications Puerperal Disorders Urogenital Diseases Uterine Hemorrhage

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women presenting with a post partum hemorrhage
needing sulprostone infusion
during third trimester of pregnancy

Exclusion criteria

known coagulation disorders

Treatment and study plan

thromboelastography

Diagnostic Test

TEG5000® : Kaolin and Functional Fibrinogen tests on native blood sample

Primary outcomes

Calculated blood loss

Time frame: during the 24 hours after delivery

Calculated blood loss at 24 hours after delivery (Sum of the volume of blood transfused and the volume of blood loss calculated by the decrease in hematocrit.)

Sponsors and collaborators

Lead sponsor

Hôpital Armand Trousseau

Other

Registry information

Official study title

Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage : a Retrospective Study

Important dates

Study start: 2012
Primary completion: 2015
Study completion: 2015
First posted: Feb 28, 2018
Registry last updated: Feb 28, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed